Skip to main content
SpringerLink
Log in

Alemtuzumab

Type 1 diabetes mellitus and autoimmune thyroiditis: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Richter S, et al. Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease. Journal of Neurology 266: 1270-1271, No. 5, May 2019. Available from: URL: http://doi.org/10.1007/s00415-019-09257-5 - Germany

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1753, 21 (2019). https://doi.org/10.1007/s40278-019-61913-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-61913-7

Search

Navigation